Skip to main content
Clinical Trials/CTRI/2021/08/035524
CTRI/2021/08/035524
Completed
Phase 3

Clinical Evaluation and Therapeutic Management of Mantha Sanni (Autism Spectrum disorder) by Uthaamani Nei( Internal) along with Nellikkai Thylam (External)

ational Institute of Siddha0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
ational Institute of Siddha
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Children of age group under 3\-12 years Clinically diagnosed as Autism Spectrum Disorder (ASD)
  • Meets the diagnostic symptoms of
  • Has poor eye contact
  • Inappropriate emotional response
  • Acquired speech or lost it
  • Engages in stereotyped and repetitive behaviour
  • Unusual sensitive to sensory stimuli

Exclusion Criteria

  • \-H/O Attention deficit hyperactivity disorder(ADHD)
  • H/O Seizures and epilepsy
  • H/O Cerebral palsy
  • H/O Hearing and visual impairments
  • H/O Congenital anomalies
  • Any other serious illness

Outcomes

Primary Outcomes

Not specified

Similar Trials